傲农生物: 北京市中伦律师事务所关于福建傲农生物科技集团股份有限公司2024年年度股东大会的法律意见书

Core Points - The legal opinion letter confirms the compliance of the 2024 annual shareholders' meeting of Fujian Aonong Biological Technology Group Co., Ltd. with relevant laws and regulations [1][2][3] - The meeting was convened by the board of directors and followed the proper procedures for notification and voting [4][5][13] Group 1: Meeting Procedures - The notice for the 2024 annual shareholders' meeting was published 20 days prior, in accordance with the Company Law and Shareholders' Meeting Rules [2][4] - The meeting was held at the company's conference room, presided over by the chairman, Su Mingcheng, and utilized an online voting system [3][5] Group 2: Attendance and Voting - A total of 439 shareholders and their proxies attended the meeting, representing 859,421,183 shares, which is 39.2573% of the total voting shares [4][5] - The voting results indicated that all resolutions were passed with more than half of the voting rights present, and special resolutions received over two-thirds approval [7][9][13]